FDA mobile medical apps

By MHN Staff April 13, 2015
By Bradley Merrill Thompson With the growth of health apps, entrepreneurs often need to determine if FDA regulates their particular mobile app. As I’ve explained in other posts and indeed in a book, that question has a number of facets to it, but in this post I want to focus on the most important – the intended use of the app. This concept of intended use is indeed not just the determining factor...
By Brian Dolan January 12, 2015
Last year Verizon stopped offering both its patient-to-provider Virtual Visits product and its FDA-cleared telehealth hub software. This moves Verizon away from end-to-end telehealth products and re-focuses it on providing its healthcare customers HIPAA-ready cloud services, advanced security services, and various mobility solutions. MedCity News first reported on one of the telehealth product...
By Brian Dolan June 24, 2014
On Friday the FDA issued a draft guidance document that revealed the agency intends to further deregulate medical device data systems (MDDS) and some medical image transfer systems. The FDA wrote that these types of devices are so low risk that they won't be regulating them at all. Examples of health software platforms that have class 1 medical device clearance as an MDDS includes Validic's...
By Brian Dolan June 16, 2014
As MobiHealthNews noted last week in the introduction to our In-Depth report on Apple's Health app feature set, the FDA made a rare move on Wednesday by adding a new description for a type of mobile medical app that it would not regulate as a medical device. The FDA has actually added a total of four such new descriptions to its list in 2014. It just so happened that the latest app description to...
By Brian Dolan May 1, 2014
Vital Connect's HealthPatch This past month the FDA cleared two mobile medical apps and one digital health platform as 510(k) Class II medical devices. McKesson, one of the most vocal health IT companies lobbying for changes to how the FDA regulates medical software, secured clearance for a mobile medical app called McKesson Cardiology ECG Mobile. The web-based version of McKesson Cardiology...
By Brian Dolan March 13, 2014
Baltimore, Maryland-based WellDoc, one of the earliest and best known mobile health companies focused on diabetes management, has appointed Kevin McRaith as the company's new president. McRaith most recently served as VP of Sales & Marketing at Human Genome Sciences, and previously worked at Genentech, Abbott and Baxter. In this role McRaith will report to WellDoc CEO Ryan Sysko. WellDoc's...
By Brian Dolan February 12, 2014
Image from the office of Senator Deb Fischer (R-Neb.) Longtime MobiHealthNews columnist Bradley Merrill Thompson, a member of the lawfirm Epstein, Becker & Green, and one of the founders of the mHealth Regulatory Coalition and the CDS Regulatory Coalition, sent over a few examples of the types of apps that a bill in Congress, called the PROTECT Act, would instruct the FDA to stop...
By MHN Staff September 30, 2013
by Bradley Merrill Thompson As just about everyone knows, last week the FDA published its final guidance on mobile medical apps. That guidance explains in plain English the types of mHealth apps the agency regulates. Over the coming weeks, many of us will be dissecting that guidance to assess what it really means and how the guidance affects the numerous apps already released, as well as those on...
By MHN Staff August 27, 2013
By Bradley Merrill Thompson I feel like a dissident trying to convince the government to free a political prisoner. That’s a pretty apt description, considering that the FDA’s Mobile Medical App (MMA) guidance document is being held hostage purely on political grounds. Earlier this year, a DC advocacy group decided they wanted Congress to adopt an entirely different approach to health IT. The...
By Brian Dolan June 25, 2013
In the next few days -- after two years of waiting -- the FDA will publish its final guidelines for mobile medical apps. That was the plan, anyway. News of the imminent publication of the guidelines prompted the Bipartisan Policy Center to make moves to put pressure on HHS to stop it. Last week the group got 129 companies and associations to sign a letter that urges the administration to hold off...

Editor's Pick